Submit or Track your Manuscript LOG-IN

Modulation of Pentylenetetrazol Induced Neuronal Circuit Epilepsy by p2y Purinoreceptor 3 (p2y3) in Sprague Dawley Rats

Modulation of Pentylenetetrazol Induced Neuronal Circuit Epilepsy by p2y Purinoreceptor 3 (p2y3) in Sprague Dawley Rats

Zhongjiang Niu1, Periyannan Velu2, Annamalai Vijayalakshmi2*

1Department of Neurology, Harbin 242 Hospital, Harbin, 150066, China.
2Galileovasan Offshore And Research And Development Pvt. Ltd, Nagapattinam, Tamil Nadu 611002, India.
 
*      Corresponding author: [email protected]

ABSTRACT

Epilepsy is a complex neurological disorder which causes abnormal electrical impulses in brain. The role of P2Y purinergic receptor in epilepsy is less known. NF45, a P2Y antagonist receptor, plays a crucial role in pentylenetetrazol (PTZ) kindled epilepsy. This study assessed the locomotion and hippocampal levels of mitochondrial complexes (IV, II, and I) in animal model. The experiment also assessed Thiobarbituric acid-reactive substance (TBARS), mean kindling score, hypertension, anxiety, discrimination ability (SNSE), learning, and memory in eight groups of rats. PTZ – kindling rats showed poor motor activity. PTZ-kindling rats showed increase in emotional tension, anxiety, learning and memory, pro-inflammatory mediators (IL-1β and TNF-α) in hippocampal tissue, neuronal damage (increased sNSE), mitochondrial dysfunction, and oxidative stress. PTZ-kindling augmented TBARS and reduced GSH and CAT. PTZ-kindling significantly decreased locomotion, memory and learning. Neuronal damage and hippocampus swelling were reversed with NF45 in a dose dependent manner. P2y agonist, methylene - ATP, significantly reduced the positive effect of NF45.P2y3 receptors had a significant role in epilepsy kindling. This mechanism has potential in epilepsy therapy and future research.

To share on other social networks, click on any share button. What are these?

Pakistan Journal of Zoology

October

Pakistan J. Zool., Vol. 56, Iss. 5, pp. 2001-2500

Featuring

Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits


Subscribe Unsubscribe